Physician

Allan Louie Espino Cruz, M.D.

According to 2025 Medicare claims, Allan Cruz, M.D. (NPI: 1730477555) practices hematology/oncology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Hudson, NJ. This provider's primary affiliated billing organization is BARNABAS HEALTH MEDICAL GROUP PC (NPI: 1841557246; TIN: 454832340) and primary practice location at 07302-4240. Cruz is affiliated with the RWJBH Accountable Care, LLC (ACO ID: A1247) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under both the MSSP and REACH models.

Cruz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 104 traditional Medicare patients, billed 279 HCPCS/CPT codes, and received $34,782 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 889 prescription claims across 115 beneficiaries totaling $1,722,800 in drug costs, led by Ibrance (Palbociclib). 2023 DME data shows 63 claims. Open Payments data shows 1 records totaling $18. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $5,681 to $1,722,800. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	127	302	$22,112
2018	244	698	$49,621
2019	348	827	$61,460
2020	251	658	$47,675
2021	216	449	$39,916
2022	76	374	$37,309
2023	82	272	$30,102
2024	104	279	$34,782

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	36	75	$5,681
2016	30	133	$5,105
2017	70	197	$100,920
2018	121	732	$1,034,547
2019	190	918	$1,167,764
2020	205	1,146	$2,218,974
2021	160	874	$2,054,096
2022	94	850	$1,291,165
2023	92	726	$1,977,615
2024	115	889	$1,722,800

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	11	$1,890
2020	N/R	13	$1,901
2021	N/R	13	$250
2022	N/R	45	$1,027
2023	N/R	63	$3,727
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	34	34	$178
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	33	58	$151
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	14	17	$137
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	63	141	$106
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	13	15	$103

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	44	1,232	$711,554
Abiraterone Acetate	Abiraterone Acetate	12	360	$55,407
Venclexta	Venetoclax	11	308	$19,385
Eliquis	Apixaban	21	750	$14,635
Neupogen	Filgrastim	14	408	$9,606

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$18	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Allan Louie Espino Cruz, M.D.?

Tedicare shows public-source Medicare data for Allan Louie Espino Cruz, M.D. (NPI 1730477555), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Allan Louie Espino Cruz, M.D. have ACO affiliation data?

Allan Louie Espino Cruz, M.D. is shown with ACO affiliation data for RWJBH Accountable Care, LLC (MSSP, ACO ID A1247) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Allan Louie Espino Cruz, M.D.?

Allan Louie Espino Cruz, M.D. is linked to BARNABAS HEALTH MEDICAL GROUP PC (billing NPI 1841557246) in the available physician profile data.

Does Allan Louie Espino Cruz, M.D. have Open Payments data?

Allan Louie Espino Cruz, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.